JJ PHARMA
JJ Pharma, Inc., a biotechnology company, produces microbial fermentations for therapeutic fields. The company primarily focuses on developing drug compounds for cardiovascular and arthritis diseases, as well as cancer and tuberculosis. It offers JJP-10 and JJP-11, which are water-soluble cholesterol altering compounds that minimize liver and muscle toxicity, as well as prevent drug interactions; and JJP-12, a water-soluble small molecule produced from microorganisms that reduces arthritis. JJ Pharma, Inc. was founded in 2004 and is based in San Francisco, California.
JJ PHARMA
Industry:
Biotechnology Health Care Medical
Founded:
2004-01-01
Address:
San Francisco, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
255 K USD
Similar Organizations
Trygg Pharma Holding AS
Trygg Pharma Holding AS is a biotechnology company producing omega 3 fatty acids for pharmaceutical applications.
UVLrx Therapeutics
UVLrx Therapeutics is a biotechnology company that specializes in the fields of medical, healthcare, and therapeutics.
Current Employees Featured
Founder
More informations about "JJ PHARMA"
JJ Pharma Company Profile | Management and Employees List
JJ Pharma Profile and History JJ Pharma, Inc. is a biopharmaceutical company developing small molecule therapeutics to treat diseases with significant unmet needs in the areas of metabolic …See details»
Johnson & Johnson: Changing health for humanity
More than 200 conditions are classified as rheumatic diseases, including rheumatoid arthritis, lupus and Sjögren’s disease. They tend to affect the joints and connective tissues, causing …See details»
Johnson & Johnson's Organizational Structure …
Johnson & Johnson (J&J) is an American multinational organization that develops consumer goods, pharmaceuticals, and medical devices. Founded in 1886 by three brothers — Robert Wood, James Wood, and Edward Mead Johnson — …See details»
JJ Pharma - Overview, News & Similar companies | ZoomInfo.com
JJ Pharma, Inc. is a biopharmaceutical company developing small molecule therapeutics to treat diseases with significant unmet needs in the areas o f metabolic disorders including metabolic …See details»
Johnson & Johnson - Wikipedia
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock …See details»
Meet our leadership team - Janssen
Sep 26, 2024 As Executive Vice President, Pharmaceuticals, R&D and Johnson & Johnson (J&J) Executive Committee member, John’s mission is to focus the best research and …See details»
JJ PHARMA - Drug pipelines, Patents, Clinical trials - Synapse
Last update 02 May 2024. JJ PHARMA. Private Company |See details»
Discover J&J | Changing the trajectory of health for …
Discover J&J Resources for veterans, military and military families Johnson & Johnson is proud to lead in support of the United States military-connected community: from military service members to veterans to military families & …See details»
JJ PHARMA - Contacts, Employees, Board Members, Advisors
JJ Pharma, Inc., a biotechnology company, produces microbial fermentations for therapeutic fields.See details»
Johnson & Johnson (J&J) PESTEL Analysis - The ... - The …
Legal. Regulatory Approvals: As a pharmaceutical and medical device company, J&J’s products must gain approval from regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency …See details»
Introducing Johnson & Johnson Innovative Medicine | Home
Sep 19, 2024 The Janssen Pharmaceutical Companies of Johnson & Johnson is now J&J Innovative Medicine. We’ve been part of Johnson & Johnson and now our identity better …See details»
J&J, world's largest drugmaker, plans to split in two
Nov 12, 2021 Pharmaceuticals would account for about two-thirds of that total. J&J intends to have the structure of its consumer health business outlined by the end of 2022. As a …See details»
Johnson & Johnson Announces Plans to Accelerate Innovation, …
Nov 12, 2021 The Pharmaceutical and Medical Devices segments, which are expected to generate revenue of approximately $77 billion in Full-Year 2021, are united by their shared …See details»
Ahead of key Stelara patent cliff, J&J's pharma ... - Fierce Pharma
Jan 23, 2024 Worldwide, J&J’s pharma business reeled in $13.72 billion during the fourth quarter, a 4% increase from the same period in 2022. On the immunology front, ...See details»
JJ PHARMA - Tech Stack, Apps, Patents & Trademarks - Crunchbase
JJ PHARMA . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by Aberdeen Section. This …See details»
Investor Relations | Johnson & Johnson
Oct 15, 2024 The J&J value. At Johnson & Johnson, we believe health is everything. We are building a world where complex diseases are prevented, treated and cured, treatments are …See details»
J&J sees potential for 14 new multibillion-dollar drugs by 2025
Nov 18, 2021 J&J said last week that it plans to spin off its consumer health division that sells Listerine and Band-Aid bandages in order to focus on pharmaceuticals and medical devices in …See details»
Johnson & Johnson - Statistics & Facts | Statista
Feb 22, 2024 Leading global pharmaceutical companies based on pharma revenue in 2022 (in billion U.S. dollars) Premium Statistic Roche Group's total sales 2006-2023 Roche Group's …See details»
Johnson & Johnson Expands to Canada | Johnson & Johnson Our …
Image courtesy: Johnson & Johnson Archives. After operating a Canadian sales force for three decades, Johnson & Johnson opened its first factory outside of the United States in 1919.See details»